Back to Search Start Over

The Endothelial Glycocalyx: Physiology and Pathology in Neonates, Infants and Children.

Authors :
Puchwein-Schwepcke A
Genzel-Boroviczény O
Nussbaum C
Source :
Frontiers in cell and developmental biology [Front Cell Dev Biol] 2021 Sep 01; Vol. 9, pp. 733557. Date of Electronic Publication: 2021 Sep 01 (Print Publication: 2021).
Publication Year :
2021

Abstract

The endothelial glycocalyx (EG) as part of the endothelial surface layer (ESL) is an important regulator of vascular function and homeostasis, including permeability, vascular tone, leukocyte recruitment and coagulation. Located at the interface between the endothelium and the blood stream, this highly fragile structure is prone to many disruptive factors such as inflammation and oxidative stress. Shedding of the EG has been described in various acute and chronic diseases characterized by endothelial dysfunction and angiopathy, such as sepsis, trauma, diabetes and cardiovascular disease. Circulating EG components including syndecan-1, hyaluronan and heparan sulfate are being evaluated in animal and clinical studies as diagnostic and prognostic markers in several pathologies, and advances in microscopic techniques have enabled in vivo assessment of the EG. While research regarding the EG in adult physiology and pathology has greatly advanced throughout the last decades, our knowledge of the development of the glycocalyx and its involvement in pathological conditions in the pediatric population is limited. Current evidence suggests that the EG is present early during fetal development and plays a critical role in vessel formation and maturation. Like in adults, EG shedding has been demonstrated in acute inflammatory conditions in infants and children and chronic diseases with childhood-onset. However, the underlying mechanisms and their contribution to disease manifestation and progression still need to be established. In the future, the glycocalyx might serve as a marker to identify pediatric patients at risk for vascular sequelae and as a potential target for early interventions.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2021 Puchwein-Schwepcke, Genzel-Boroviczény and Nussbaum.)

Details

Language :
English
ISSN :
2296-634X
Volume :
9
Database :
MEDLINE
Journal :
Frontiers in cell and developmental biology
Publication Type :
Academic Journal
Accession number :
34540845
Full Text :
https://doi.org/10.3389/fcell.2021.733557